| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/06/2005 | EP1549277A1 Induction and maintenance of tolerance to composite tissue allografts |
| 07/06/2005 | EP1549144A2 Methods for treating cancer by inhibiting wnt signaling |
| 07/06/2005 | EP1549140A2 Production of peptides in plants as viral coat protein fusions |
| 07/06/2005 | EP1222280B1 Apoptosis inducing proteinaceous substance |
| 07/06/2005 | EP1145013B1 Removal of prions from blood, plasma and other liquids |
| 07/06/2005 | EP1071442B1 Methods and compositions for peptide synthesis (t-20) |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1636019A Recombinant antibodies, and compositions and methods for making and using the same |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635908A Antibodies that immunospecifically bind to trail receptors |
| 07/06/2005 | CN1635906A Method of preventing cell death using antibodies to neural thread proteins |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1634992A Method for optimizing and extracting rabbit-anti-human ATP7Bn33-629 polyclone antibodies |
| 07/06/2005 | CN1634991A Human anti-tetanotoxin monoclonal antibody, method for preparation and application |
| 07/06/2005 | CN1634990A High affinity immune globulin binding molecule and method for preparation |
| 07/06/2005 | CN1634989A Bacillus coli resisting chicken yolk antibody, its preparation and use |
| 07/06/2005 | CN1209374C Human Protein for promoting transform of 3T3 cell and its coding sequence |
| 07/06/2005 | CN1209373C Human protein with suppression to cancer cell growth and its coding sequence |
| 07/06/2005 | CN1209370C New human protein with cancer inhibiting function and its encoding sequence |
| 07/06/2005 | CN1209369C Cell death inducing protein and its coding sequence and use |
| 07/05/2005 | US6914130 Compositions and methods for the diagnosis and treatment of tumor |
| 07/05/2005 | US6914129 Anti-IgE antibodies |
| 07/05/2005 | US6914128 Comprises immunoglobulin for treatment and prevention of inflammatory and autoimmune diseases |
| 07/05/2005 | US6914125 Scramblase 2 |
| 07/05/2005 | US6913907 Enterococcus faecalis polynucleotides encoding EF059 |
| 07/05/2005 | US6913906 Thaumatin protein for use in intensifying food flavor |
| 07/05/2005 | US6913894 Monoclonal antibody for use in the treatment of tumors |
| 07/05/2005 | US6913756 Monoclonal antibodies specific for anthrax and peptides derived from the antibodies thereof |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | US6913747 Humanized immunoglobulin reactive with B7 therewith |
| 07/05/2005 | US6913745 Passive immunization of Alzheimer's disease |
| 07/05/2005 | CA2280875C Remedies for lymphocytic tumors |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2129663C Biosynthetic binding protein for cancer marker |
| 07/05/2005 | CA2123811C Type i and type ii surface antigens associated with staphylococcus epidermidis |
| 06/30/2005 | WO2005059515A2 Method for treating neurological disorders |
| 06/30/2005 | WO2005059504A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34) |
| 06/30/2005 | WO2005059138A1 Methods and compounds for altering the load of hepatitis virus |
| 06/30/2005 | WO2005059106A2 Interferon alpha antibodies and their uses |
| 06/30/2005 | WO2005058967A2 Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof |
| 06/30/2005 | WO2005058966A2 Use of ligands of specific antigen for the diagnosis and treatment of solid tumours and bone-related cancerous diseases |
| 06/30/2005 | WO2005058965A1 Methods and compositions for inhibiting c-met dimerization and activation |
| 06/30/2005 | WO2005058964A1 Antibody against modified valosine-containing protein |
| 06/30/2005 | WO2005058963A1 Anti-hiv antibody |
| 06/30/2005 | WO2005058962A1 Methods of therapy and diagnosis using targeting of cells that express bclp polypeptides |
| 06/30/2005 | WO2005058961A2 Antibodies specific for human galanin, and uses thereof |
| 06/30/2005 | WO2005058957A2 Ztnf 12, a tumor necrosis factor |
| 06/30/2005 | WO2005058952A2 Ztnf13, a tumor necrosis factor |
| 06/30/2005 | WO2005058948A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/30/2005 | WO2005058865A2 Assay for entactogens |
| 06/30/2005 | WO2005058864A1 Assay for entactogens |
| 06/30/2005 | WO2005058815A2 Ip-10 antibodies and their uses |
| 06/30/2005 | WO2005058365A1 Pharmaceutical preparation containing an antibody for the egf receptor |
| 06/30/2005 | WO2005058359A2 Method for neutralizing effects of crp for increasing immune reactions to hiv |
| 06/30/2005 | WO2005058358A2 Use of agents derived from ceacam1 for the treatment of inflammatory diseases |
| 06/30/2005 | WO2005058353A1 Passive immunization against clostridium difficile disease |
| 06/30/2005 | WO2005058352A2 Treatment of rheumatoid arthritis with galectin-3 antagonists |
| 06/30/2005 | WO2005058351A2 Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkers |
| 06/30/2005 | WO2005058251A2 Hla-dr-specific antibodies, compositions and methods |
| 06/30/2005 | WO2005058244A2 Novel anti-dc-sign antibodies |
| 06/30/2005 | WO2005058236A2 Cab molecules |
| 06/30/2005 | WO2005058234A2 Methods and compositions relating to ccr5 antagonist, ifn-ϝ and il-13 induced inflammation |
| 06/30/2005 | WO2005044989A3 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same |
| 06/30/2005 | WO2005041992A3 Colostrum compositions and methods |
| 06/30/2005 | WO2005040206A8 Glurp-msp3 fusion protein, immunogenic compositions and malarial vaccines containing it |
| 06/30/2005 | WO2005032343A3 Hedgehog signaling in prostate regeneration neoplasia and metastasis |
| 06/30/2005 | WO2005021576A3 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same |
| 06/30/2005 | WO2005009369A3 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/30/2005 | WO2005002529A3 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 06/30/2005 | WO2004108766A3 Anti-hgf-r antibodies and their use |
| 06/30/2005 | WO2004103293A3 Modulators of the p2y10 receptor useful in altering t lymphocyte function |
| 06/30/2005 | WO2004063343A3 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 06/30/2005 | WO2004058178A3 Uses of mammalian cytokine; related reagents |
| 06/30/2005 | WO2004037999A3 A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same |
| 06/30/2005 | WO2004035611A3 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 06/30/2005 | WO2004033658A3 Recombinant catalytic polypeptides and their uses |
| 06/30/2005 | WO2004018999A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2004001381A3 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 06/30/2005 | WO2003068801A3 Antibody variants with faster antigen association rates |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143929 Protein engineering with analogous contact environments |
| 06/30/2005 | US20050143566 exhibits an improved stability at increased pH-values, and accordingly an improved tolerance to cleaning under alkaline conditions; tolerant to one or more cleaning procedures using alkaline agents |
| 06/30/2005 | US20050143562 Administering bone polypeptide-1 expressed by a nucleic acid for treating a bone disorder or osteoporosis of a patient |
| 06/30/2005 | US20050143308 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/30/2005 | US20050143307 Biological activity that prevents the binding of formyl methionine-leucine-phenylalanine (fMLP) and/or C5a protein to granulocytes; acute and chronic inflammation reactions and HIV infection |
| 06/30/2005 | US20050142649 Covalently reactive transition state analogs and methods of use thereof |
| 06/30/2005 | US20050142644 Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same |
| 06/30/2005 | US20050142635 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
| 06/30/2005 | US20050142634 Novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof |
| 06/30/2005 | US20050142625 monoclonal antibodies or antigen-binding fragments having specific binding affinity to an epitope of protein kinases polypeptides, used for the diagnosis and treatment of various kinase-related diseases in humans |
| 06/30/2005 | US20050142620 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/30/2005 | US20050142619 monoclonal antibodies that preferentially bind to cell surface proteins of pancreatic cells; medical diagnosis; immunology |
| 06/30/2005 | US20050142616 Diagnostic test for neuropsychiatric systemic lupus erythematosus |
| 06/30/2005 | US20050142609 Native immunoglobulin binding reagents and methods for making and using same |